What the FDA found The FDA reviewed Belle Health website in December 2025 and identified that their website displayed semaglutide and tirzepatide products with Belle branding in a way that suggested Belle manufactured or compounded these drugs
De Raeve HR, Thunnissen FB, Kaneko FT, Guo FH, Lewis M, et al: Decreased Cu, Zn-SOD activity in asthmatic airway epithelium: correction by inhaled corticosteroid in vivo
Research shows that for every batch of SLU-PP-332 and 5-Amino-1MQ, full information on chemical structure, composition and quality specifications is available to support researchers in their laboratory studies
Mounjaro also received NICE approval for weight management in 2024, giving NHS services another option
Dopaminergic neuroprotective effects of rotigotine via 5-HT1A receptors: possibly involvement of metallothionein expression in astrocytes